Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuyuki Yasuda

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy|June 24, 2016
Independent Risk Factors for Positive and Negative Symptoms in Patients with Diabetic PolyneuropathyReo Inoue, Masahiko Sumitani, Tetsuyuki Yasuda, et al.
Diabetes Research and Clinical Practice|December 17, 2010
YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patientsTetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, et al.
Journal of Diabetes Investigation|August 30, 2019
Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1-year periodDan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, et al.
Journal of Diabetes Investigation|May 17, 2018
Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patientsDan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, et al.
Internal Medicine (Tokyo, Japan)|March 25, 2025
A Case of Thyrotoxicosis and Excess Iodine Due to Habitual Use of Polyvinylpyrrolidone Iodine while Gargling in an Iodine-sufficient AreaKanako Sato, Hiroaki Asai, Saori Yoshioka, et al.
Diabetology International|March 31, 2021
Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinomaHiroki Yamaguchi, Yumika Miyoshi, Yuhei Uehara, et al.
Diabetology International|August 5, 2024
Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infectionKeisuke Murakawa, Hiroaki Aasi, Kanako Sato, et al.
Journal of Atherosclerosis and Thrombosis|September 13, 2002
NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjectsRieko Hayaishi-Okano, Yoshimitsu Yamasaki, Kentaro Ohtoshi, et al.
Journal of Diabetes Investigation|January 27, 2015
Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluatedSaeko Osawa, Tetsuyuki Yasuda, Hideaki Kaneto, et al.
Atherosclerosis|October 18, 2008
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetesNaoto Katakami, Munehide Matsuhisa, Hideaki Kaneto, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Pain & Palliative Care Pharmacotherapy|June 24, 2016
Independent Risk Factors for Positive and Negative Symptoms in Patients with Diabetic PolyneuropathyReo Inoue, Masahiko Sumitani, Tetsuyuki Yasuda, et al.
Diabetes Research and Clinical Practice|December 17, 2010
YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patientsTetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, et al.
Journal of Diabetes Investigation|August 30, 2019
Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1-year periodDan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, et al.
Journal of Diabetes Investigation|May 17, 2018
Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patientsDan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, et al.
Internal Medicine (Tokyo, Japan)|March 25, 2025
A Case of Thyrotoxicosis and Excess Iodine Due to Habitual Use of Polyvinylpyrrolidone Iodine while Gargling in an Iodine-sufficient AreaKanako Sato, Hiroaki Asai, Saori Yoshioka, et al.
Diabetology International|March 31, 2021
Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinomaHiroki Yamaguchi, Yumika Miyoshi, Yuhei Uehara, et al.
Diabetology International|August 5, 2024
Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infectionKeisuke Murakawa, Hiroaki Aasi, Kanako Sato, et al.
Journal of Atherosclerosis and Thrombosis|September 13, 2002
NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjectsRieko Hayaishi-Okano, Yoshimitsu Yamasaki, Kentaro Ohtoshi, et al.
Journal of Diabetes Investigation|January 27, 2015
Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluatedSaeko Osawa, Tetsuyuki Yasuda, Hideaki Kaneto, et al.
Atherosclerosis|October 18, 2008
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetesNaoto Katakami, Munehide Matsuhisa, Hideaki Kaneto, et al.
Pageof 9